Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation

Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for treatment as SGA is reported to be 1:1800. The latest data from the National Registry of Growth Hormone therapy (RNAOC) showed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tornese, Gianluca, Pricci, Flavia, Pellegrin, Maria Chiara, Villa, Marika, Rotondi, Daniela, Agazio, Elvira, Barbi, Egidio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805524/
https://www.ncbi.nlm.nih.gov/pubmed/31639023
http://dx.doi.org/10.1186/s13052-019-0715-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805524/
https://www.ncbi.nlm.nih.gov/pubmed/31639023
http://dx.doi.org/10.1186/s13052-019-0715-x

Ejemplares similares